Scynexis (SCYX) Other financing activities (2014 - 2026)
Scynexis' (SCYX) quarterly Other financing activities came in at $17000.0 in Q1 2026, down 34.62% YoY from $26000.0 in Q1 2025, and down 32.0% on a QoQ basis from $25000.0 in Q3 2025.
Scynexis (SCYX) Other financing activities (2014 - 2026) Analysis & Trends
Scynexis (SCYX) has 13 years of Other financing activities data on file, last reported at $17000.0 in Q1 2026.
- Quarterly Other financing activities fell 34.62% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42000.0 (down 26.32% YoY) and the FY2025 annual result came in at $51000.0, down 8.93% from the prior year.
- Other financing activities slipped to $17000.0 in Q1 2026, from $25000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $38000.0 in Q3 2023 to a low of $4000.0 in Q1 2023.
- A 5-year average of $20444.4 and a median of $25000.0 in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities sank 60.0% — and 2024, when it jumped 525.0%.
- Tracing SCYX's Other financing activities over 5 years: stood at $8000.0 in 2022, then surged by 375.0% to $38000.0 in 2023, then slipped by 18.42% to $31000.0 in 2024, then retreated by 19.35% to $25000.0 in 2025, then slumped by 32.0% to $17000.0 in 2026.
- The last three Other financing activities figures came in at $17000.0 (Q1 2026), $25000.0 (Q3 2025), and $26000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |